Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysis

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1438-1440

  Harding, Stephen ^a   Provot, Francois ^b   Beuscart, Jean Baptise ^b   Cook, Mark ^c   Bradwell, Arthur R ^d   Stringer, Stephanie ^c   White, Darren ^a   Cockwell, Paul ^c   Hutchison, Colin A ^c  

^a Binding Site Group Ltd   (United Kingdom)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

cast nethropathy; high cut off haemodialysis; serum free light chain

Indexed keywords

BORTEZOMIB; CREATININE; DEXAMETHASONE; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; CELL PROLIFERATION; CREATININE BLOOD LEVEL; DEHYDRATION; DENSITOMETRY; DYSURIA; FEMALE; GASTROENTERITIS; GEL PERMEATION CHROMATOGRAPHY; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY TUMOR; MOLECULAR WEIGHT; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS;

CHROMATOGRAPHY, GEL; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RENAL DIALYSIS;

EID: 79953850783     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr019     Document Type: Article

References (12)

1. Hutchison CA, Cockwell P, Reid S et al. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in-vitro and in-vivo studies. J Am Soc Nephrol 2007; 18: 886-895 (Pubitemid 46434505)
2. Hutchison CA, Bradwell AR, Cook M et al. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol 2009; 4: 745-754
3. Hutchison CA, Cook M, Heyne N et al. European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial. Trials 2008; 9: 55
4. Hutchison CA, Plant T, Drayson M et al. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. BMC Nephrol 2008; 9: 11
5. Leung N, Gertz MA, Zeldenrust SR et al. Improvement of cast ne-phropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int 2008; 73: 1282-1288 (Pubitemid 351693147)
6. Clark WF, Stewart AK, Rock GA et al. Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Ann Intern Med 2005; 143: 777-784
7. Hutchison CA, Harding S, Mead G et al. Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care. Artif Organs 2008; 32: 910-917
8. de Kat Angelino CM, Raymakers R, Teunesen MA et al. Over estimation of serum kappa free light chain concentration by immunone-phelometry. Clin Chem 2010; 56: 7
9. Mead GP, Carr-Smith HD. Over estimation of serum kappa free light chain concentration by immunonephelometry. Clin Chem 2010; 56: 9
10. Mead GP, Stubbs PD, Carr-Smith HD et al. Nephelometric measurement of serum free light chains in non-secretory myeloma. Clin Chem 2002; 48: 70
11. Abraham RS, Clark RJ, Bryant SC et al. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma. Clin Chem 2002; 48: 655-657 (Pubitemid 34261233)
12. Harding SJ, Sharp K, Steiner A et al. Quantification of polymerising serum free light chains. Clin Lymphoma Myeloma 2009; 9: B101a